methotrexate has been researched along with Atheroma in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, W; Han, B; Hou, J; Hou, S; Huang, X; Liu, D; Liu, Q; Lv, H; Nie, H; Sun, Y; Wang, G; Wang, X; Yang, M; Yu, B; Zhang, L; Zhang, R | 1 |
| Carvalho, PO; Gomes, FLT; Hatab, SA; Higuchi, ML; Kalil-Filho, R; Maranhão, RC; Mattos, FR; Pitta, FG; Serrano, CV; Tavares, ER | 1 |
| Dumont, N; Goldminz, AM; Gottlieb, AB; Krueger, JG; Suárez-Fariñas, M; Wang, AC | 1 |
| Arida, A; Fragiadaki, K; Kitas, GD; Konstantonis, G; Protogerou, AD; Sfikakis, PP | 1 |
| Arbab-Zadeh, A; Kiani, AN; Lima, J; Magder, LS; Petri, M; Vogel-Claussen, J | 1 |
5 other study(ies) available for methotrexate and Atheroma
| Article | Year |
|---|---|
Atheroprotective effects of methotrexate via the inhibition of YAP/TAZ under disturbed flow.
Topics: Adaptor Proteins, Signal Transducing; Adenylate Kinase; Animals; Apoptosis; Atherosclerosis; Atorvastatin; Cell Nucleus; Gene Silencing; Hemorheology; Human Umbilical Vein Endothelial Cells; Humans; Male; Methotrexate; Mice, Inbred C57BL; Models, Biological; Phosphorylation; Plaque, Atherosclerotic; Trans-Activators; Transcription Factors; Transcriptional Coactivator with PDZ-Binding Motif Proteins; YAP-Signaling Proteins | 2019 |
Regression of Atherosclerotic Plaques of Cholesterol-Fed Rabbits by Combined Chemotherapy With Paclitaxel and Methotrexate Carried in Lipid Core Nanoparticles.
Topics: Animals; Aorta; Aortic Diseases; Atherosclerosis; Cardiovascular Agents; Cholesterol, Dietary; Cytokines; Disease Models, Animal; Drug Compounding; Drug Therapy, Combination; Inflammation Mediators; Lipids; Liposomes; Male; Matrix Metalloproteinase 9; Methotrexate; Nanoparticles; Paclitaxel; Plaque, Atherosclerotic; Rabbits | 2018 |
Methotrexate improves pro- and anti-atherogenic genomic expression in psoriatic skin.
Topics: Cardiotonic Agents; Cardiovascular Diseases; Clinical Trials as Topic; Gene Expression Regulation; Genomics; Humans; Methotrexate; Plaque, Atherosclerotic; Psoriasis; Skin | 2016 |
Atherosclerosis is not accelerated in rheumatoid arthritis of low activity or remission, regardless of antirheumatic treatment modalities.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Atherosclerosis; Biological Factors; Carotid Artery Diseases; Carotid Intima-Media Thickness; Case-Control Studies; Disease Progression; Female; Femoral Artery; Humans; Male; Methotrexate; Middle Aged; Plaque, Atherosclerotic; Prednisolone; Vascular Stiffness | 2017 |
Semiquantified noncalcified coronary plaque in systemic lupus erythematosus.
Topics: Adult; Aged; Angiography; Antibodies, Antinuclear; Antirheumatic Agents; Calcinosis; Calcium; Coronary Artery Disease; Coronary Vessels; DNA; Female; Humans; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Plaque, Atherosclerotic; Risk Factors; Tomography, X-Ray Computed | 2012 |